Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Firms / Collinson Howe & Lennox II, LLC

Collinson Howe & Lennox II, LLC

Institutional venture firm · probableStamford, CTchlmedical.comSEC exempt reporting adviserpart of CHL Medical Partners

One of 3 advisers that share chlmedical.com; the firm is CHL Medical Partners. CHL Medical Partners III, LLC, Collinson Howe & Lennox, LLC. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.

venture manager with no reported fund assets yet (scale unknown)

Importance
16
moderate
Active deployment
0
low
Emerging
0
low
Completeness
38
elevated
Freshness
97
high
Research priority
5
low
Identity and regulatory footprint
Headquarters
Stamford, CTadviserinfo.sec.gov
Office address
1055 WASHINGTON BOULEVARD, Stamford, CT, 06901adviserinfo.sec.gov
Business phone
203-324-7700adviserinfo.sec.gov
Website
HTTPS://WWW.CHLMEDICAL.COM
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
unknown
Latest Form ADV
Apr 28, 2014
Private funds reported
2 (2 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$122Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
Owners on Schedule A
Indian Chase, Inc. (Owner Class A), B; Jeffrey J. Collinson Irrevocable Trust-2011 (Shareholder), C
business phone
203-324-7700adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
Sectors
not stated or not yet read
Stages
not stated or not yet read
Geography
not stated
Check size
not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
0 reported
No vehicle on record yet. A fund arrives from Form ADV Schedule D 7.B.(1) or a Form D filing.
Investment team
11 current, 0 departed
John Joseph Newbury
Trustee · since Nov 1, 2011
Board or advisory
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Jeffrey Joseph Collinson
Ceo · since May 1, 2001
Founder or executive
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Andrew Joseph Collinson
Shareholder · since Jul 1, 2006
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Anne Berry Howe
Owner Class A, B, C · since Dec 1, 2007
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Christianne Amon Collinson
Shareholder · since Jul 1, 2006
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Robin Collinson Newman
Shareholder · since Jul 1, 2006
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
RAE P. Pittman
Secretary · since May 1, 2001
Platform and operations
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Gregory Mark Weinhoff
Vice President / Owner Class A, C · since Jan 1, 2011
Vice president
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Myles David Greenberg
Vice President / Owner Class A, C · since May 1, 2011
Vice president
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Ronald William Lennox
Vice President / Owner Class A, C · since May 1, 2011
Vice president
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Timothy Furnivall Howe
Executive Vice President / Owner Class A, B, C · since May 1, 2001
Vice president
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
1 relationships from shared deals, counted for the whole firm
Canaan Partners 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
3 dated events
  1. Mar 30, 2012
    Collinson Howe & Lennox II, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)
    First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  2. Mar 30, 2012
    CHL Medical Partners II, L.P. first reported on Form ADV by Collinson Howe & Lennox II, LLC (Venture Capital Fund), GAV $113,731,791
    Fund first reported on Form ADVFundsFactCHL Medical Partners II, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  3. Mar 30, 2012
    CHL Medical Partners II Side Fund, L.P. first reported on Form ADV by Collinson Howe & Lennox II, LLC (Venture Capital Fund), GAV $7,841,097
    Fund first reported on Form ADVFundsFactCHL Medical Partners II Side Fund, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
  1. Sep 12, 2026
    Institutional venture firm (probable, 70%, cls-1)
    venture manager with no reported fund assets yet (scale unknown)
Evidence
15 observations from 1 source
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
SEC adviser typeexempt_reporting_adviserApr 28, 2014FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2012-03-30Apr 28, 2014FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2014-04-28Apr 28, 2014FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture share of reported funds1Apr 28, 2014FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone203-324-7700Apr 28, 2014FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
HeadquartersStamford, CTApr 28, 2014FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address1055 WASHINGTON BOULEVARD, Stamford, CT, 06901Apr 28, 2014FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Legal formLimited Liability CompanyApr 28, 2014FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private funds reported2Apr 28, 2014FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$122MApr 28, 2014FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture funds reported2Apr 28, 2014FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
WebsiteHTTPS://WWW.CHLMEDICAL.COMApr 28, 2014FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)